Aptamer Technologies in Neuroscience, Neuro-Diagnostics and Neuro-Medicine Development
Aptamers developed using in vitro Systematic Evolution of Ligands by Exponential Enrichment (SELEX) technology are single-stranded nucleic acids 10–100 nucleotides in length. Their targets, often with specificity and high affinity, range from ions and small molecules to proteins and other biological...
Main Authors: | Bang Wang, Firas Kobeissy, Mojtaba Golpich, Guangzheng Cai, Xiaowei Li, Reem Abedi, William Haskins, Weihong Tan, Steven A. Benner, Kevin K. W. Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-03-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/29/5/1124 |
Similar Items
-
Aptamers for Anti-Viral Therapeutics and Diagnostics
by: Tae-Hyeong Kim, et al.
Published: (2021-04-01) -
Recent Progress and Opportunities for Nucleic Acid Aptamers
by: Jonghoe Byun
Published: (2021-02-01) -
Molecular Application of Aptamers in the Diagnosis and Treatment of Cancer and Communicable Diseases
by: Philisiwe Fortunate Molefe, et al.
Published: (2018-09-01) -
Editorial: Nucleic acid-based aptamers in therapeutics and diagnostics
by: Anna Aviñó, et al.
Published: (2024-01-01) -
Neuro-Optometry, Neuro-Optometrist, and Neuro-Optometric Rehabilitative Implications
by: Ali Nouraeinejad
Published: (2019-01-01)